Abstract
dc:description.abstractC1-inhibitor is the major control protein of the classical pathway of complement. In man, its hereditary deficiency results in the clinical condition of hereditary angio-oedema (HAE). The disease is characterised by recurrent episodes of acute, circumscribed, non-inflammatory oedema involving the subcutaneous tissues and mucous membranes. Acquired C1-inhibitor deficiency can also occur without any previous family history, at a later stage in life and is usually associated with a lymphoproliferative disorder or paraproteinaemia. C1-inhibitor deficiency is treated by the administration of anabolic steroids, such as danazol or stanozolol, which are known to increase hepatic synthesis of C1-inhibitor, resulting in an increase in plasma C1-inhibitor.
Degree
thesis:*- Level dc:type.qualificationlevel
- PhD
- Grantor dc:publisher.institution
- University of Glasgow
- Year dc:date.issued
- 1987
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Jones, Linda Margaret
Rights
- Language dc:language
- en